Procter & Gamble Stock Plummets -5.3% With 5-Day Losing Streak
Procter & Gamble (PG) – a provider of branded beauty, personal care, and hygiene products – hit a 5-day losing streak, with cumulative losses over this period amounting to -5.3%. The company’s market cap has crashed by about $19 Bil over the last 5 days and currently stands at $336 Bil.
Is this opportunity or trap? There is a near-equal mix of good and bad in PG stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced (For details, see Buy or Sell PG).
But here is the interesting part. You are reading about this -5.3% move after it happened. The market has already priced in the news. To manage individual stock risk before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to manage stock-specific drawdowns better.
Returns vs S&P 500
- Why PG Could Outperform Estee Lauder Companies Stock
- Procter & Gamble Stock Capital Return Hits $99 Bil
- Pay Less, Gain More: PG Tops Estee Lauder Companies Stock
- Pay Less, Gain More: PG Tops Estee Lauder Companies Stock
- Why PG Could Outperform Estee Lauder Companies Stock
- Buy or Sell Procter & Gamble Stock?
The following table summarizes the return for PG stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | PG | S&P 500 |
|---|---|---|
| 1D | -0.2% | 1.1% |
| 5D (Current Streak) | -5.3% | -1.8% |
| 1M (21D) | -10.4% | -4.8% |
| 3M (63D) | -0.3% | -2.9% |
| YTD 2026 | 1.2% | -3.9% |
| 2025 | -12.3% | 16.4% |
| 2024 | 17.3% | 23.3% |
| 2023 | -0.9% | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 38 S&P constituents with 3 days or more of consecutive gains and 49 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 32 | 13 |
| 4D | 2 | 18 |
| 5D | 2 | 13 |
| 6D | 2 | 5 |
| 7D or more | 0 | 0 |
| Total >=3 D | 38 | 49 |
Key Financials for Procter & Gamble (PG)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $84.0 Bil | $84.3 Bil |
| Operating Income | $19.9 Bil | $20.5 Bil |
| Net Income | $14.9 Bil | $16.0 Bil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ1 | 2026 FQ2 |
|---|---|---|
| Revenues | $22.4 Bil | $22.2 Bil |
| Operating Income | $5.9 Bil | $5.4 Bil |
| Net Income | $4.8 Bil | $4.3 Bil |
The losing streak PG stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.